Viral Sheth is CEO and Founder of Neurosom, a neurotechnology company developing an integrated brain health platform for dementia risk reduction and healthy aging. He brings more than 20 years of experience in neurotechnology commercialization, global business development, and clinical innovation. Viral has played key roles in advancing non-invasive neurodiagnostic and neuromodulation platforms, including supporting the sale of a successful neuroscience business to Philips and later serving in a leadership role within Philips’ Neuro Emerging Business group. Under his leadership, Neurosom is advancing NIH/NIA-funded multi-center clinical studies in mild cognitive impairment, positioning sleep and glymphatic clearance as therapeutic pathways for brain longevity and cognitive resilience. In November 2025, Viral was recognized as Entrepreneur of the Year (Development Stage category) by the Oregon Entrepreneurs Network.